FDA approves first postpartum depression pill
By MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year. The Food and Drug Administration on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe
Continue Reading